Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
18,810,702
-
Total 13F shares
-
19,290,567
-
Share change
-
+648,628
-
Total reported value
-
$878,994,108
-
Put/Call ratio
-
175%
-
Price per share
-
$45.55
-
Number of holders
-
175
-
Value change
-
+$29,245,065
-
Number of buys
-
92
-
Number of sells
-
76
Institutional Holders of LEMAITRE VASCULAR INC - Common Stock (LMAT) as of Q2 2022
As of 30 Jun 2022,
LEMAITRE VASCULAR INC - Common Stock (LMAT) was held by
175 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
19,290,567 shares.
The largest 10 holders included
BlackRock Inc., Conestoga Capital Advisors, LLC, VANGUARD GROUP INC, Copeland Capital Management, LLC, Ranger Investment Management, L.P., GENEVA CAPITAL MANAGEMENT LLC, STATE STREET CORP, DIMENSIONAL FUND ADVISORS LP, CRAMER ROSENTHAL MCGLYNN LLC, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
175
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.